Potential pitfalls in MitoChip detected tumor-specific somatic mutations: a call for caution when interpreting patient data
文献类型：期刊论文
| 作者 | Palanichamy MG[*]1,2; Zhang YP[*]1,2 |
| 刊名 | BMC CANCER
 |
| 出版日期 | 2010 |
| 卷号 | 10期号:X页码:e597 |
| 通讯作者 | empalani@yahoo.com ; zhangyp1@263.net.cn |
| 合作状况 | 其它 |
| 英文摘要 | Background: Several investigators have employed high throughput mitochondrial sequencing array (MitoChip) in clinical studies to search mtDNA for markers linked to cancers. In consequence, a host of somatic mtDNA mutations have been identified as linked to different types of cancers. However, closer examination of these data show that there are a number of potential pitfalls in the detection tumor-specific somatic mutations in clinical case studies, thus urging caution in the interpretation of mtDNA data to the patients. This study examined mitochondrial sequence variants demonstrated in cancer patients, and assessed the reliability of using detected patterns of polymorphisms in the early diagnosis of cancer. Methods: Published entire mitochondrial genomes from head and neck, adenoid cystic carcinoma, sessile serrated adenoma, and lung primary tumor from clinical patients were examined in a phylogenetic context and compared with known, naturally occurring mutations which characterize different populations. Results: The phylogenetic linkage analysis of whole arrays of mtDNA mutations from patient cancerous and non-cancerous tissue confirmed that artificial recombination events occurred in studies of head and neck, adenoid cystic carcinoma, sessile serrated adenoma, and lung primary tumor. Our phylogenetic analysis of these tumor and control leukocyte mtDNA haplotype sequences shows clear cut evidence of mixed ancestries found in single individuals. Conclusions: Our study makes two prescriptions: both in the clinical situation and in research 1. more care should be taken in maintaining sample identity and 2. analysis should always be undertaken with respect to all the data available and within an evolutionary framework to eliminate artifacts and mix-ups. |
| 收录类别 | SCI |
| 语种 | 英语 |
| 公开日期 | 2010-12-17 |
| 源URL | [http://159.226.149.42:8088/handle/353002/6547]  |
| 专题 | 昆明动物研究所_分子进化基因组学 昆明动物研究所_遗传资源与进化国家重点实验室 |
| 作者单位 | 1.Laboratory for Conservation and Utilization of Bio-resources, Yunnan University, 2 North Green Lake Street, Kunming 650091, China 2.State Key Laboratory of Genetic resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China. |
| 推荐引用方式 GB/T 7714 | Palanichamy MG[*],Zhang YP[*]. Potential pitfalls in MitoChip detected tumor-specific somatic mutations: a call for caution when interpreting patient data[J]. BMC CANCER,2010,10(X):e597. |
| APA | Palanichamy MG[*],&Zhang YP[*].(2010).Potential pitfalls in MitoChip detected tumor-specific somatic mutations: a call for caution when interpreting patient data.BMC CANCER,10(X),e597. |
| MLA | Palanichamy MG[*],et al."Potential pitfalls in MitoChip detected tumor-specific somatic mutations: a call for caution when interpreting patient data".BMC CANCER 10.X(2010):e597. |
入库方式： OAI收割
来源：昆明动物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。